Sarasin & Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $306M | Buy |
|
|||||
|
2025
Q2 | $280M | Sell |
|
|||||
|
2025
Q1 | $311M | Sell |
|
|||||
|
2024
Q4 | $403M | Sell |
|
|||||
|
2024
Q3 | $387M | Sell |
|
|||||
|
2024
Q2 | $394M | Sell |
|
|||||
|
2024
Q1 | $492M | Buy |
|
|||||
|
2023
Q4 | $475M | Sell |
|
|||||
|
2023
Q3 | $498M | Sell |
|
|||||
|
2023
Q2 | $498M | Sell |
|
|||||
|
2023
Q1 | $960M | Buy |
|
|||||
|
2022
Q4 | $367M | Buy |
|
|||||
|
2022
Q3 | $308M | Buy |
|
|||||
|
2022
Q2 | $326M | Buy |
|
|||||
|
2022
Q1 | $376M | Sell |
|
|||||
|
2021
Q4 | $476M | Buy |
|
|||||
|
2021
Q3 | $396M | Buy |
|
|||||
|
2021
Q2 | $401M | Buy |
|
|||||
|
2021
Q1 | $379M | Buy |
|
|||||
|
2020
Q4 | $324M | Buy |
|
|||||
|
2020
Q3 | $254M | Buy |
|
|||||
|
2020
Q2 | $227M | Buy |
|
|||||
|
2020
Q1 | $231M | Buy |
|
|||||
|
2019
Q4 | $265M | Buy |
|
|||||
|
2019
Q3 | $276M | Buy |
|
|||||
|
2019
Q2 | $248M | Buy |
|
|||||
|
2019
Q1 | $163M | Sell |
|
|||||
|
2018
Q4 | $192M | Buy |
|
|||||
|
2018
Q3 | $163M | Buy |
|
|||||
|
2018
Q2 | $154M | Sell |
|
|||||
|
2018
Q1 | $162M | Buy |
|
|||||
|
2017
Q4 | $112M | Buy |
|
|||||
|
2017
Q3 | $63.7M | Buy |
|
|||||
|
2017
Q2 | $43.8M | Buy |
|